Ritalin La

   
Google
 
Web NewDrugInformation.com

Ritalin La


Drug - Ritalin La
The trade name of the product as shown on the labeling.

Dosage - CAPSULE, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Methylphenidate Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 40MG
The potency of the active ingredient(s), Methylphenidate Hydrochloride. May repeat for multiple part products.

Applicant - NOVARTIS
The firm name holding legal responsibility for Ritalin La. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021284
The FDA assigned number to Ritalin La. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Ritalin La. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 5, 2002
The date Ritalin La was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Ritalin La. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ritalin La is in. Format is RX, OTC, DISCN.

Applicant Full Name - Novartis Pharmaceuticals Corp
The full name of the firm holding legal responsibility for the new application of Ritalin La.

Ritalin La